-
公开(公告)号：US20240165190A1
公开(公告)日：2024-05-23
申请号：US18281545
申请日：2022-03-11
摘要： The present disclosure relates to a herbo-mineral metallic pharmaceutical kit for delaying/controlling recurrence and/or metastasis of cancer in Triple Negative Breast Cancer (TNBC) patients. The herbo-mineral metallic pharmaceutical kit comprises a first container containing Suvarna Bhasmadi Vati (SBV), a second container containing Mouktikyukta Kamdudha Vati (MKV), a third container containing Shatavari Vati (SV), a fourth container containing Arogyavardhini Vati (AVV), a fifth container containing Triphala Guggul Vati (TGV) and a sixth container containing jatamansi Oil (JMO). The herbo mineral metallic pharmaceutical kit assists in improving immunomodulatory response and reducing oxidative stress in TNBC patients.
-
公开(公告)号：US20220226419A1
公开(公告)日：2022-07-21
申请号：US17609673
申请日：2020-02-12
IPC分类号： A61K36/899 , A61K33/242 , A61K35/618 , A61K36/59 , A61K35/614 , A61K36/81 , A61K36/736 , A61K36/744 , A61K35/20 , A61K47/36
摘要： The present disclosure relates to a pharmaceutical kit for alleviating adverse effects of chemotherapy, reducing oxidative stress, improving immunomodulatory response and quality of life. The pharmaceutical kit comprises Suvarna bhasmadi Vati (SBD), Mouktikyukta Kamdudha Vati (MKD), Padmakadi Ghrut (PDG), and Ananta vati. The pharmaceutical kit of the present disclosure can be used for alleviating adverse effects of chemotherapy such as nausea, vomiting, anorexia, fever, taste alteration, fatigue, dyspepsia, and mucositis. It can also improve immune status and reduce oxidative stress leading to betterment of the quality of life of the patients treated with chemotherapy. The pharmaceutical kit of the present disclosure may be beneficial in cancers and diseases for which chemotherapy is a treatment of choice.
-
3.发明申请公开(公告)号：US20220211753A1
公开(公告)日：2022-07-07
申请号：US17609535
申请日：2020-02-12
摘要： The present disclosure relates to a pharmaceutical herbo-mineral-metallic composition and its process of preparation. The pharmaceutical herbo-mineral-metallic composition comprises Suvarna bhasma, wherein the Suvarna bhasma is obtained by stabilizing Suvarna with fresh juice of the leaves of Ocimum sanctum, Mouktik bhasma, Guduchi sattva, and at least one excipient. The pharmaceutical herbo-mineral-metallic composition of the present disclosure can be used for alleviating disease induced and therapy induced adverse effects. It can also improve quality of life of the patients as assessed by Karnofsky score and wellbeing by QLQ CTC 30 score. The pharmaceutical herbo-mineral-metallic composition of the present disclosure can be beneficial in increasing disease free survival and overall survival in various cancers. It is not toxic in nature when consumed for a long period of time.
-
4.发明申请公开(公告)号：US20220202888A1
公开(公告)日：2022-06-30
申请号：US17609601
申请日：2020-02-12
摘要： The present disclosure relates to a herbo-mineral kit for alleviating adverse effects of chemotherapy resulting into improved quality of life of patients. The herbo-mineral kit comprises a first container containing Padmakadi Ghrut (PDG) in a thick, viscous form; a second container containing Mouktikyukta Kamdudha Vati (MKD) in a solid dosage form; a third container containing Praval Pishti Vati (PPV) in a solid dosage form; and a fourth container containing Ananta vati in a solid dosage form. The herbo-mineral kit of the present disclosure can be used for alleviating adverse effects of chemotherapy such as nausea, vomiting, constipation, diarrhea, stomatitis, and skin discoloration in cancer treatment. Use of the herbo-mineral kit of the present disclosure may prove to be beneficial in all types of cancers and diseases for which chemotherapy is treatment of choice.
-
公开(公告)号：US20230248793A1
公开(公告)日：2023-08-10
申请号：US18015577
申请日：2021-07-13
IPC分类号： A61K36/484 , A61K33/242 , A61K35/618 , A61K36/185 , A61K47/44
CPC分类号： A61K36/484 , A61K33/242 , A61K35/618 , A61K36/185 , A61K47/44
摘要： The present disclosure relates to the field of polyherbal metallo-mineral pharmaceutical kit. The kit of the present disclosure can be used for alleviating adverse effects of radiotherapy, reducing oxidative stress, and improving immunomodulatory response, oral hygiene and quality of life of the patients. The polyherbal metallo-mineral pharmaceutical kit comprises Suvarna bhasmadi Vati (SBV), Mouktikyukta Kamdudha Vati (MKV), Yashtimadhu Ghrut (YTG), Yashtimadhu Taila (YTO), Ananta Vati (AV) and Gandush Churna (GC).
-
公开(公告)号：US20230233601A1
公开(公告)日：2023-07-27
申请号：US18011164
申请日：2021-07-05
IPC分类号： A61K33/242 , A61K33/10 , A61K31/718 , A61K36/71 , A61K47/36 , A61K35/618 , A61K35/614 , A61K35/35 , A61K9/20 , A61P35/00
CPC分类号： A61K33/242 , A61K33/10 , A61K31/718 , A61K36/71 , A61K47/36 , A61K35/618 , A61K35/614 , A61K35/35 , A61K9/2072 , A61K9/2095 , A61P35/00
摘要： The present disclosure relates to a herbo-mineral metallic pharmaceutical kit and a process for its preparation. The herbo-mineral metallic pharmaceutical kit comprises Suvarna Bhasmadi Vati (SBV), Mouktikyukta Kamdudha Vati (MKV), Trailokyachintamani Rasa Vati (TCR), Kumari Kalpa Vati (KKV) and Khadirarishta (KHA). The herbo-mineral metallic pharmaceutical kit of the present disclosure can be used for delaying and/or controlling the recurrence or occurrence of breast and/or ovarian cancer in second breast and/or ovary or metastasis. The herbo-mineral metallic pharmaceutical compositions of the kit assist in reducing oxidative stress, improving immune status and quality of life and maintaining a disease-free survival in patients who are genetically predisposed to breast or ovarian cancer.
-
公开(公告)号：US20220211794A1
公开(公告)日：2022-07-07
申请号：US17609643
申请日：2020-02-12
IPC分类号： A61K36/899 , A61K36/736 , A61K36/24 , A61K35/20
摘要： The present disclosure relates to a herbo-lipid composition for alleviating symptoms related to inflammation resulting into improved quality of life. The herbo-lipid composition comprises an extract of petals and stalks of Padmak, an extract of whole Durva plant, and decoction of roots of Ananta, which are processed in cow's ghee. The herbo-lipid composition of the present disclosure can be used internally for alleviating symptoms of inflammation mainly in erythematous skin rash. Its topical application is also beneficial in radiotherapy induced adverse effects like burning micturition, burning in vagina, dysuria, diarrhea and pain in lower abdomen in cervical cancer patient and stomatitis, and local burning in oral cancer patients. The composition also helps in reducing radiotherapy and chemotherapy induced adverse effects in various types of cancers when given orally.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.012 秒)
